ANI Pharmaceuticals Inc Cash Flow-to-Debt Ratio
ANI Pharmaceuticals Inc cash flow-to-debt ratio. ANI Pharmaceuticals Inc (ANIP) has a Cash Flow-to-Debt Ratio of 0.03x as of December 2025, meaning its operating cash flow of $30.37 Million could theoretically repay 0% of its total liabilities ($899.65 Million) in one year. Check ANI Pharmaceuticals Inc (ANIP) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of ANI Pharmaceuticals Inc (1998–2025)
Cash flow-to-debt ratio of ANI Pharmaceuticals Inc from 1998 to 2025. Historical debt coverage capacity for ANI Pharmaceuticals Inc across 28 annual periods. Check ANI Pharmaceuticals Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
ANI Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (1998–2025)
ANI Pharmaceuticals Inc cash flow-to-debt ratio by year from 1998 to 2025. Year-by-year debt coverage analysis for ANI Pharmaceuticals Inc. For the full cash flow conversion analysis, see ANIP cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.21x | $185.22 Million | $899.65 Million | ▲ +175.0% |
| 2024 | 0.07x | $64.02 Million | $855.17 Million | ▼ -71.9% |
| 2023 | 0.27x | $118.96 Million | $446.82 Million | ▲ +459.7% |
| 2022 | -0.07x | $-31.20 Million | $421.55 Million | ▼ -1019.9% |
| 2021 | 0.01x | $3.32 Million | $412.86 Million | ▼ -86.0% |
| 2020 | 0.06x | $15.27 Million | $265.49 Million | ▼ -69.3% |
| 2019 | 0.19x | $45.63 Million | $244.00 Million | ▼ -34.9% |
| 2018 | 0.29x | $67.07 Million | $233.34 Million | ▲ +73.1% |
| 2017 | 0.17x | $39.42 Million | $237.38 Million | ▼ -7.4% |
| 2016 | 0.18x | $27.47 Million | $153.22 Million | ▲ +30.0% |
| 2015 | 0.14x | $17.26 Million | $125.18 Million | ▼ -22.4% |
| 2014 | 0.18x | $22.03 Million | $123.92 Million | ▲ +111.5% |
| 2013 | -1.55x | $-5.48 Million | $3.54 Million | ▲ +35.1% |
| 2012 | -2.39x | $-25.28 Million | $10.59 Million | ▼ -22.5% |
| 2011 | -1.95x | $-47.87 Million | $24.56 Million | ▼ -24.5% |
| 2010 | -1.57x | $-40.10 Million | $25.62 Million | ▼ -75.0% |
| 2009 | -0.89x | $-18.43 Million | $20.61 Million | ▲ +77.8% |
| 2008 | -4.03x | $-15.54 Million | $3.85 Million | ▼ -926.0% |
| 2007 | 0.49x | $739.99K | $1.52 Million | ▲ +142.0% |
| 2006 | -1.16x | $-5.00 Million | $4.30 Million | ▲ +61.4% |
| 2005 | -3.01x | $-8.30 Million | $2.76 Million | ▲ +45.0% |
| 2004 | -5.48x | $-10.44 Million | $1.91 Million | ▲ +12.6% |
| 2003 | -6.27x | $-5.52 Million | $881.21K | ▼ -98.7% |
| 2002 | -3.15x | $-3.96 Million | $1.26 Million | ▼ -60.5% |
| 2001 | -1.97x | $-1.82 Million | $927.76K | ▲ +42.3% |
| 2000 | -3.41x | $-3.21 Million | $941.26K | ▲ +37.3% |
| 1999 | -5.43x | $-1.79 Million | $329.12K | ▼ -46.1% |
| 1998 | -3.72x | $-3.04 Million | $817.91K | — |